Literature DB >> 3055962

Immunobiology of IgA.

J Mestecky1.   

Abstract

In humans, IgA is produced in quantities larger than those of all other immunoglobulin isotypes combined. In comparison with immunoglobulin of other isotypes, human IgA displays a unique heterogeneity of its molecular forms with a characteristic distribution in various body fluids. Serum IgA is represented by predominantly monomeric molecules of the IgA1 subclass and is produced mainly in the bone marrow, while in external secretions most of the IgA, produced locally in mucosal tissues, occurs in the polymeric configuration with a relatively increased proportion of IgA2 molecules. Cells that produce monomeric or polymeric IgA and IgA1 or IgA2 molecules are characteristically distributed in various lymphoid and nonlymphoid tissues. The differential interactions of monomeric and polymeric IgA molecules with various cells lead to their selective distribution in body fluids and to differences in the effector functions. Contrary to immunoglobulins of other isotypes, IgA participates in the disposal of antigens by mechanisms mostly devoid of inflammatory consequences. Various modes of immunization can induce an immune response in the systemic and/or secretory IgA compartments. Although most of the total serum IgA is momomeric, recent studies indicate that specific serum IgA antibodies induced by either mucosal or systemic immunizations with microbial antigens appear first in the polymeric form. Thus, cautious immunochemical analyses of IgA antibodies in systemic and secretory compartments with respect to their kinetics of appearance, monomeric and polymeric forms, and subclass may elucidate their tissue origin and character of the antigen involved in their induction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3055962     DOI: 10.1016/s0272-6386(88)80029-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  16 in total

Review 1.  Dysfunctions of the Iga system: a common link between intestinal and renal diseases.

Authors:  Christina Papista; Laureline Berthelot; Renato C Monteiro
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Antibody Responses to SARS-CoV-2: Let's Stick to Known Knowns.

Authors:  Nicole Baumgarth; Janko Nikolich-Žugich; F Eun-Hyung Lee; Deepta Bhattacharya
Journal:  J Immunol       Date:  2020-09-04       Impact factor: 5.422

3.  Hyper-immunoglobulin A in the hyperimmunoglobulinemia D syndrome.

Authors:  I S Klasen; J H Göertz; G A van de Wiel; C M Weemaes; J W van der Meer; J P Drenth
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

4.  Characterization of B-cell responses to Chlamydia trachomatis antigens in humans with trachoma.

Authors:  S Ghaem-Maghami; R L Bailey; D C Mabey; P E Hay; O S Mahdi; H M Joof; H C Whittle; M E Ward; D J Lewis
Journal:  Infect Immun       Date:  1997-12       Impact factor: 3.441

5.  Antirotavirus immunoglobulin A neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea.

Authors:  F M Ruggeri; K Johansen; G Basile; J P Kraehenbuhl; L Svensson
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium.

Authors:  P Michetti; M J Mahan; J M Slauch; J J Mekalanos; M R Neutra
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

7.  A murine model of chronic mucosal colonization by Pseudomonas aeruginosa.

Authors:  G B Pier; G Meluleni; E Neuger
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

8.  Role of interleukin-4 (IL-4) and IL-10 in serum immunoglobulin G antibody responses following mucosal or systemic reovirus infection.

Authors:  Alicia R Mathers; Christopher F Cuff
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

Review 9.  IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.

Authors:  Jan Novak; Bruce A Julian; Milan Tomana; Jiri Mestecky
Journal:  Semin Nephrol       Date:  2008-01       Impact factor: 5.299

10.  IgA1 and IgA2 subclass antibodies against Klebsiella pneumoniae in the sera of patients with peripheral and axial types of ankylosing spondylitis.

Authors:  O Mäki-Ikola; M Nissilä; K Lehtinen; M Leirisalo-Repo; K Granfors
Journal:  Ann Rheum Dis       Date:  1995-08       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.